person

J. B.

Country
The Netherlands
Department
Nephrology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 84 partner sites.

Specializations

Nephrology and Kidney Disorders

Investigator J. Balak concentrates on renal failure and related metabolic complications within the field of nephrology.

  • Chronic kidney disease
  • Kidney failure
  • Steroid‑sensitive idiopathic nephrotic syndrome

These interests align with the clinical setting at Haga Hospital.

Cardiovascular and Atherosclerotic Disease

The investigator’s work includes prevention and treatment of atherosclerotic cardiovascular disease and associated thrombotic events.

  • Acute myocardial infarction
  • Peripheral arterial disease
  • Atrial fibrillation
  • Elevated lipoprotein(a)

Research emphasizes primary prevention strategies and management of high‑risk cardiac patients.

Oncology – Solid Tumors

J. Balak is active in clinical studies targeting major solid‑tumor entities, focusing on novel therapeutic combinations.

  • Non‑Small Cell Lung Cancer
  • Renal cell carcinoma
  • Metastatic breast cancer
  • Colorectal cancer
  • Urothelial carcinoma

Efforts aim to improve progression‑free and overall survival across these malignancies.

Hematology – Leukemia and Lymphoma

The investigator engages in studies of blood‑cell malignancies, emphasizing targeted and immunotherapeutic approaches.

  • Acute myeloid leukemia
  • Chronic lymphocytic leukemia
  • Diffuse large B‑Cell lymphoma
  • Multiple myeloma
  • Mantle cell lymphoma

Clinical focus includes maintenance strategies and measurable residual disease assessment.

Rare and Immune‑Mediated Disorders

Research extends to uncommon conditions where immune dysregulation plays a central role.

  • AL amyloidosis
  • ANCA‑associated vasculitis
  • Cystic fibrosis
  • Behçet’s disease
  • Sickle cell disease

These projects aim to evaluate disease‑modifying therapies for patients with limited treatment options.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.